These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 26227779)

  • 1. Discovery of novel potent and selective ligands for 5-HT2A receptor with quinazoline scaffold.
    Deng X; Guo L; Xu L; Zhen X; Yu K; Zhao W; Fu W
    Bioorg Med Chem Lett; 2015 Sep; 25(18):3970-4. PubMed ID: 26227779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and biological evaluation of 4-nitroindole derivatives as 5-HT2A receptor antagonists.
    Hayat F; Viswanath AN; Pae AN; Rhim H; Park WK; Choo HY
    Bioorg Med Chem; 2015 Mar; 23(6):1313-20. PubMed ID: 25684421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5-HT
    Ostrowska K; Grzeszczuk D; Głuch-Lutwin M; Gryboś A; Siwek A; Leśniak A; Sacharczuk M; Trzaskowski B
    Bioorg Med Chem; 2018 Jan; 26(2):527-535. PubMed ID: 29269256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proof of concept study for designed multiple ligands targeting the dopamine D2, serotonin 5-HT2A, and muscarinic M1 acetylcholine receptors.
    Szabo M; Lim HD; Herenbrink CK; Christopoulos A; Lane JR; Capuano B
    J Med Chem; 2015 Feb; 58(3):1550-5. PubMed ID: 25590655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and biological investigation of new equatorial (β) stereoisomers of 3-aminotropane arylamides with atypical antipsychotic profile.
    Stefanowicz J; Słowiński T; Wróbel MZ; Herold F; Gomółka AE; Wesołowska A; Jastrzębska-Więsek M; Partyka A; Andres-Mach M; Czuczwar SJ; Łuszczki JJ; Zagaja M; Siwek A; Nowak G; Żołnierek M; Bączek T; Ulenberg S; Belka M; Turło J
    Bioorg Med Chem; 2016 Sep; 24(18):3994-4007. PubMed ID: 27377863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New arylpiperazinylalkyl derivatives of 8-alkoxy-purine-2,6-dione and dihydro[1,3]oxazolo[2,3-f]purinedione targeting the serotonin 5-HT1A /5-HT2A /5-HT7 and dopamine D2 receptors.
    Chłoń-Rzepa G; Zagórska A; Bucki A; Kołaczkowski M; Pawłowski M; Satała G; Bojarski AJ; Partyka A; Wesołowska A; Pękala E; Słoczyńska K
    Arch Pharm (Weinheim); 2015 Apr; 348(4):242-53. PubMed ID: 25773907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of structural effects on 5-HT(2A) receptor antagonism by aporphines: identification of a new aporphine with 5-HT(2A) antagonist activity.
    Ponnala S; Gonzales J; Kapadia N; Navarro HA; Harding WW
    Bioorg Med Chem Lett; 2014 Apr; 24(7):1664-7. PubMed ID: 24630561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-based design of PDZ ligands as inhibitors of 5-HT(2A) receptor/PSD-95 PDZ1 domain interaction possessing anti-hyperalgesic activity.
    Vogrig A; Dorr L; Bouzidi N; Boucherle B; Wattiez AS; Cassier E; Vallon G; Ripoche I; Abrunhosa-Thomas I; Marin P; Nauton L; Thery V; Courteix C; Lian LY; Ducki S
    ACS Chem Biol; 2013 Oct; 8(10):2209-16. PubMed ID: 23895101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and biological evaluation of a series of aminoalkyl-tetralones and tetralols as dual dopamine/serotonin ligands.
    Carro L; Torrado M; Raviña E; Masaguer CF; Lage S; Brea J; Loza MI
    Eur J Med Chem; 2014 Jan; 71():237-49. PubMed ID: 24316025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis, and preliminary in vitro and in vivo pharmacological evaluation of 2-{4-[4-(2,5-disubstituted thiazol-4-yl)phenylethyl]piperazin-1-yl}-1,8-naphthyridine-3-carbonitriles as atypical antipsychotic agents.
    Gowri Chandra Sekhar KV; Rao VS; Deuther-Conrad W; Reddy AS; Brust P; Krishna Kumar MM
    J Enzyme Inhib Med Chem; 2011 Aug; 26(4):561-8. PubMed ID: 21171898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel 4-alkyl-1-arylpiperazines and 1,2,3,4-tetrahydroisoquinolines containing diphenylmethylamino or diphenylmethoxy fragment with differentiated 5-HT1A/5-HT2A/D2 receptor activity.
    Paluchowska MH; Mokrosz MJ; Charakchieva-Minol S; Duszyńska B; Kozioł A; Wesołowska A; Stachowicz K; Chojnacka-Wójcik E
    Pol J Pharmacol; 2003; 55(4):543-52. PubMed ID: 14581712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C4 phenyl aporphines with selective h5-HT(2B) receptor affinity.
    Kapadia N; Harding WW
    Bioorg Med Chem Lett; 2015 Sep; 25(17):3451-4. PubMed ID: 26227772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and biological evaluation of thioadatanserin and its dialkylated products as partial 5-HTR
    Evans CA; Zuluaga A; Vasquez Matute D; Baradaran-Noviri S; Perez-Cervantes N; Siegler MA
    Bioorg Med Chem Lett; 2020 Aug; 30(16):127358. PubMed ID: 32631554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New aporphinoid 5-HT2A and α1A antagonists via structural manipulations of nantenine.
    Chaudhary S; Ponnala S; Legendre O; Gonzales JA; Navarro HA; Harding WW
    Bioorg Med Chem; 2011 Oct; 19(19):5861-8. PubMed ID: 21900013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, Synthesis, and Pharmacological Characterization of Heterobivalent Ligands for the Putative 5-HT
    Poulie CBM; Liu N; Jensen AA; Bunch L
    J Med Chem; 2020 Sep; 63(17):9928-9949. PubMed ID: 32815361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and activity of functionalizable derivatives of the serotonin (5-HT) 5-HT
    Gilbertson SR; Chen YC; Soto CA; Yang Y; Rice KC; Cunningham KA; Anastasio NC
    Bioorg Med Chem Lett; 2018 May; 28(8):1381-1385. PubMed ID: 29555153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding modes of chain arylpiperazines to 5-HT1a, 5-HT2a and 5-HT7 receptors.
    Bielenica A; Kozioł AE; Struga M
    Mini Rev Med Chem; 2013 Aug; 13(10):1516-39. PubMed ID: 24568298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New 5-HT
    Fiorino F; Magli E; Kędzierska E; Ciano A; Corvino A; Severino B; Perissutti E; Frecentese F; Di Vaio P; Saccone I; Izzo AA; Capasso R; Massarelli P; Rossi I; Orzelska-Gòrka J; Kotlińska JH; Santagada V; Caliendo G
    Bioorg Med Chem; 2017 Oct; 25(20):5820-5837. PubMed ID: 28943244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reformulating a Pharmacophore for 5-HT2A Serotonin Receptor Antagonists.
    Younkin J; Gaitonde SA; Ellaithy A; Vekariya R; Baki L; Moreno JL; Shah S; Drossopoulos P; Hideshima KS; Eltit JM; González-Maeso J; Logothetis DE; Dukat M; Glennon RA
    ACS Chem Neurosci; 2016 Sep; 7(9):1292-9. PubMed ID: 27385190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overcoming Depression with 5-HT
    Zięba A; Stępnicki P; Matosiuk D; Kaczor AA
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.